ORMP Research and Charts

ORMP - Oramed Pharmaceuticals Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-12 (Delayed quote data 2025-01-06)

Last 2.45	Change ⇑ +0.01 (+0.41%)	Volume 79,707
	Open 2.44	High 2.47	Low 2.40

8EMA (Daily) 2.41	40EMA (Daily) 2.40	50EMA (Daily) 2.40	STO (Daily) 49.600	MACD Hist (Daily) 0.007
8EMA (Weekly) 2.403	40EMA (Weekly) 2.46	50EMA (Weekly) 2.54	STO (Weekly) 53.660	MACD Hist (Weekly) 0.041


Company Profile
Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.